All News

Article

ACR23 – Day 3 Report

Jack Cush, MD

These year’s annual ACR Convergence has been a success with the return of an insanely active Poster Hall! F2F learning amidst miles of research and many young talented aside wizened establish presenters is such a welcome return to ACR, the way it should be.

Article

#ACRbest Abstracts – Day 3

Jack Cush, MD

Today was a big day for the Plenaries, Curbside Consults, ACR Business meeting (and induction of our new ACR President Dr. Deborah Desir) and Late-Breaking Posters. Our hot-button reporters have compiled these #ACRbest abstracts for you! (November 14, 2023 at #ACR23)

Leonard Calabrese Tweet
LCalabreseDO
Kevin. Winthrop knocks it down on WHO is immunocompromised among rheumatic disease pts at Innovation Theater ⁦@CCalabreseDO⁩ #ACR23 ⁦@alhkim⁩ ⁦@AdamJBrownMD⁩ ⁦@ELittlejohnDO⁩ https://t.co/4hFtQgvaIf
Md Yuzaiful Md Yusof Tweet
#ACR23 Late-Breaking Abstr#L10 Phase 2 crossover RCT of Dazodalibep, in #Sjogren pts with low ESSDAI but high ESSPRI. ESSPRI and FACIT-FATIGUE improved in both Stage 1 and also after X-over after 159 days. One to look out for those with high symptoms burden @RheumNow #ACRBest https://t.co/yGGrPmUOHU
Mithu Maheswaranathan, MD Tweet
🆕 2023 ACR Guidelines for Management of Interstitial Lung Disease (#ILD) in Systemic Autoimmune Rheumatic Diseases 🫁 🔸 Screening & Monitoring Recs 🔸 Treatment Guidelines ILD/RP-ILD #RheumTwitter #PulmTwitter #MedTwitter #MedX https://t.co/JreVO0kgEf
Paul Sufka, MD Tweet
psufka
My takeaways from #ACR23 #ReviewCourse session on Inflammatory Eye Disease - Dr. Laura Kopplin: 1. Systemic therapy has better long term outcomes than topical treatments, but many/most ophthalmologists are uncomfortable with prescribing there. 2. FAST Trial: Methotrexate better… https://t.co/eoSeWVHsf0
Bella Mehta Tweet
bella_mehta
Development of New classification crieteria to target patients earlier in thier #OA disease course! One tatget molecule will not solve this heterogeneous disease! @rheumnow #ACR23 https://t.co/waynA6RdUg
Dr. Antoni Chan Tweet
A new innovative way of teaching MS ultrasound to students using teledidactic teaching with portable ultrasound devices resulted in a significant increase in knowledge comparable to the conventional course, Schäfer SV, Abst#2079 #ACR23 @RheumNow https://t.co/re0gErx5ke https://t.co/yPbS9Rj0az
TheDaoIndex Tweet
KDAO2011
The patients’ voice matters! Watch my interview with @LAlupusLady regarding how she manages #Lupus and her perspective about the disease @rheumnow #ACR23 @uptoTate https://t.co/P9KPJQEkRv
Robert B Chao, MD Tweet
All of us need to remind each other to take care of yourself! Some tips from Dr. Whitney Marvin - exercise, date night, talking to a friend - take breaks, mindfulness - eating away from computer (as I type this on my desk, next to my lunch) @RheumNow #ACR23 https://t.co/UmmDqXRECN
Janet Pope Tweet
#Cardiology imaging has advanced - work with #cardiologists to know what to order - esp for our Pts w #inflammatory #diseases #ACR23 ⁦@RheumNow⁩ ⁦@ACRheum⁩ 14T118 https://t.co/RuHJuy7Dh2
Dr. Antoni Chan Tweet
Editorial position on the use of AI in publishing. AI cannot be listed as an author ✍️ Smolen J, #ACR23 @RheumNow https://t.co/P2eOmi6W5c
Dr. Rachel Tate Tweet
Prof Schett provides #ACR23 a wonderful, easy to digest, review of how CAR-T works. @RheumNow https://t.co/y5HZVAvvhy
Meral K. El Ramahi, MD Tweet
MeralElRamahiMD
Dx: Idiopathic granulomatous mastitis ➡️median age: 30 yo ➡️usually 2yrs after breast feeding ➡️RF: hyperprolactinemia, leads to pro-inflam effect ➡️Extra-mammary manifestat: arthralgia, episcleritis, skin changes mimicking autoimm dz ➡️Tx: steroid + AZA vs MTX #ACR23 @RheumNow https://t.co/lGT2UUIkoM
TheDaoIndex Tweet
KDAO2011
Read my article on ACR Plenaries: Changing the Practice of Rheumatology #ACR23 @ACRheum @RheumNow @uptoTate @Yuz6Yusof @ericdeinmd https://t.co/ql851dVzAk
TheDaoIndex Tweet
KDAO2011
In case you missed it! Watch our ACR Monday Recap of the meeting with me, @RheumNow @EBRheum and @ericdeinmd. #ACR23 @uptoTate https://t.co/GpMdev0Yk7
How well do you know this week's rheumatology news?
Take the rheumIQ quiz
Take the RheumIQ Quiz

×